Interim results of a multiple ascending dose study of R1626, a novel nucleoside analog targeting HCV polymerase in chronic hcv patients

---

Autoria(s): Roberts, R.; Cooksley, G.; Shaw, D.; Berns, H. K.; Brandl, M. T.; Fettner, S. H.; Hill, G.; Ipe, D.; Klumpp, K.; Mannino, M.; O'Mara, E.; Tuo, Y.; Washington, C. B.

Data(s)	01/01/2006
Identificador	http://espace.library.uq.edu.au/view/UQ:80233
Idioma(s)	eng
Publicador	Elesevier Science
Palavras-Chave	#Liver #HCV polymerase #Patients #CX #1103 Clinical Sciences
Tipo	Conference Paper